Removable covers for drug eluting medical devices
US-2024024642-A1 · Jan 25, 2024 · US
US2016015864A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016015864-A1 |
| Application number | US-201514859913-A |
| Country | US |
| Kind code | A1 |
| Filing date | Sep 21, 2015 |
| Priority date | Apr 1, 2013 |
| Publication date | Jan 21, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A coating composition capable of forming a drug coating layer unsusceptible to peeling in the process of delivery of a water-insoluble drug to a target tissue is provided. The coating composition contains the water-insoluble drug and a basic compound which is positively charged at physiological pH. A medical device coated with the coating composition is further provided.
Opening claim text (preview).
What is claimed is: 1 . A coating composition to be used for a drug-eluting medical device, the coating composition containing a water-insoluble drug and a basic compound which is positively charged at physiological pH. 2 . The coating composition according to claim 1 , wherein the basic compound is at least one selected from the group consisting of a basic compound having an amidino group, a basic compound having a piperidine ring, a basic compound having two or more amino groups in one molecule thereof, a quaternary ammonium cation, and salts thereof. 3 . The coating composition according to claim 1 , wherein the basic compound is at least one selected from the group consisting of compounds represented by the following general formula (I) and salts thereof: where A is an aromatic ring, R 1 and R 2 are each independently an alkyl or alkenyl group of 10 to 25 carbon atoms, X 1 and X 2 are each independently O, S, COO, OCO, CONH or NHCO, m is 0 or 1, and n is 0 or an integer of 1 to 6. 4 . The coating composition according to claim 1 , wherein the basic compound is at least one selected from the group consisting of compounds represented by the following general formula (II) and salts thereof: where R 3 and R 4 are each independently an alkyl group of 10 to 18 carbon atoms. 5 . The coating composition according to claim 1 , wherein the basic compound is at least one selected from the group consisting of compounds represented by the following general formula (III) and salts thereof: where R 5 are each independently an alkyl group of 10 to 18 carbon atoms. 6 . The coating composition according to claim 1 , wherein the basic compound is at least one selected from the group consisting of compounds represented by the following general formula (IV) and salts thereof: where R 6 are each independently an alkyl group of 10 to 18 carbon atoms. 7 . The coating composition according to claim 1 , wherein the basic compound is 3,5-dipentadecyloxybenzamidine and/or a salt thereof. 8 . The coating composition according to claim 1 , further containing a lower alcohol. 9 . The coating composition according to claim 8 , wherein the lower alcohol is glycerin. 10 . The coating composition according to claim 1 , wherein the water-insoluble drug is at least one selected from the group consisting of rapamycin, paclitaxel, docetaxel, and everolimus. 11 . The coating composition according to claim 1 , wherein the medical device is a medical device which can be expanded in a radial direction within a lumen. 12 . The coating composition according to claim 11 , wherein the medical device is a balloon or a catheter. 13 . A drug coating layer formed, by use of the coating composition according to claim 1 , on at least part of a surface of the medical device. 14 . A medical device provided with the drug coating layer according to claim 13 . 15 . A treating method comprising: delivering the medical device according to claim 14 into a lumen; radially expanding the medical device within the lumen; and eluting a drug from the drug coating layer formed on at least part of the surface of the medical device and permitting the drug to act on the lumen.
Materials for coatings · CPC title
the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin · CPC title
Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title
Coatings containing a mixture of two or more compounds · CPC title
having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.